| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human OX40/TNFRSF4 Fc Chimera Protein, CF |
|---|
| Description | Purity >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 70 kDa, reducing conditions. MW (theoretical): 46.7 kDa (monomer). The Recombinant Human OX40/TNFRSF4 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human OX40/TNFRSF4 Fc Chimera Protein has been validated for the following applications: Binding Activity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Binding Activity |
|---|
| Other Names | ACT-135, ACT35 antigen, ACT35ATC35 antigen, CD134, CD134 antigen, Ly-70, OX40 cell surface antigen, OX40 homologue, OX40L receptor, OX40lymphoid activation antigene ACT35, TAX transcriptionally-activated glycoprotein 1 receptor, tax-transcriptionally activated glycoprotein 1 receptor, TNFRSF4, tumor necrosis factor receptor superfamily member 4, tumor necrosis factor receptor superfamily, member 4, Txgp1, TXGP1L, TXGP1LOX40 antigen |
|---|
| Gene, Accession, CAS # | TNFRSF4, Gene ID: 7293, Accession: P43489 |
|---|
| Catalog # | 3388-OX-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human OX40/TNFRSF4 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 20519625 |
|---|
| 产品资料 |
|
|